DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Cohen H, Hunt BJ, Efthymiou M. et al; RAPS trial investigators.
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematol 2016;
3 (09) e426-e436
We do not assume any responsibility for the contents of the web pages of other providers.